Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddu545PMID 25343993PMCID PMC4321443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease.

  2013cited by this paper
• NMD: a multifaceted response to premature translational termination

  2012cited by this paper
• A zebrafish model of lethal congenital contracture syndrome 1 reveals Gle1 function in spinal neural precursor survival and motor axon arborization

  2012cited by this paper
• Rapid screening of innate immune gene expression in zebrafish using reverse transcription - multiplex ligation-dependent probe amplification

  2011cited by this paper
• Gle1 Is a Multifunctional DEAD-box Protein Regulator That Modulates Ded1 in Translation Initiation*

  2011cited by this paper
• Restless legs syndrome‐associated MEIS1 risk variant influences iron homeostasis

  2011cited by this paper
• Pom121 links two essential subcomplexes of the nuclear pore complex core to the membrane

  2010cited by this paper
• Control of mRNA Export and Translation Termination by Inositol Hexakisphosphate Requires Specific Interaction with Gle1*

  2010cited by this paper
• TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

  2010cited by this paper
• MutationTaster evaluates disease-causing potential of sequence alterations

  2010cited by this paper
• The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS).

  2010cited by this paper
• Conflict of interest statement. None declared.

  2010cited by this paper
• Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease

  2008cited by this paper
• The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation.

  2008cited by this paper
• Characterization and prediction of alternative splice sites.

  2006cited by this paper
• Chk1 is required to maintain Claspin stability

  2006cited by this paper
• Evidence that Poly(A) Binding Protein C1 Binds Nuclear Pre-mRNA Poly(A) Tails

  2006cited by this paper
• Interaction between the shuttling mRNA export factor Gle1 and the nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA.

  2005cited by this paper
• Distribution and intensity of constraint in mammalian genomic sequence.

  2005cited by this paper
• The mRNA Export Factor Human Gle1 Interacts with the Nuclear Pore Complex Protein Nup155*

  2004cited by this paper
• An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export

  2003cited by this paper
• A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The Snf1 protein kinase and its activating subunit, Snf4, interact with distinct domains of the Sip1/Sip2/Gal83 component in the kinase complex

  1997cited by this paper
• Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast.

  1996cited by this paper
• An RNA-export mediator with an essential nuclear export signal

  1996cited by this paper
• Lethal arthrogryposis with anterior horn cell disease.

  1995cited by this paper
• A lethal autosomal recessive syndrome of multiple congenital contractures.

  1985cited by this paper
• Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines

  1984cited by this paper
• Amino Acid Difference Formula to Help Explain Protein Evolution

  1974cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy

  2025cites this paper
• Entering the era of precision medicine to treat amyotrophic lateral sclerosis

  2025cites this paper
• Nuclear pore complex dysfunction drives TDP-43 pathology in ALS

  2025cites this paper
• In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responses

  2025cites this paper
• The nuclear envelope and nuclear pore complexes in neurodegenerative diseases

  2025cites this paper
• cAMP/PKA signaling regulates TDP-43 aggregation and mislocalization

  2024cites this paper
• GLE1 dysfunction compromises cellular homeostasis, spatial organization, and peripheral axon branching

  2024cites this paper
• Advances in the understanding of nuclear pore complexes in human diseases

  2024cites this paper
• Nuclear pore dysfunction and disease: a complex opportunity

  2024cites this paper
• Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin β-1 granules.

  2023cites this paper
• Muscular phenotype description of abnormal THOC2 splicing.

  2023cites this paper
• Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS

  2023influential citation
• Neurogenetic motor disorders.

  2023cites this paper
• Integrative genetic analysis illuminates ALS heritability and identifies risk genes

  2023cites this paper
• Nuclear mRNA Export and Aging

  2022cites this paper
• Posttranscriptional regulation of neurofilament proteins and tau in health and disease

  2022cites this paper
• Structure and Function of the Nuclear Pore Complex.

  2022cites this paper
• Nuclear Pore Dysfunction in Neurodegeneration

  2022influential citation
• Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD

  2022cites this paper
• Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors

  2022cites this paper
• DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Peripheral neuropathy linked mRNA export factor GANP reshapes gene regulation in human motor neurons

  2021cites this paper
• The Great Escape: mRNA Export through the Nuclear Pore Complex

  2021cites this paper
• Loss of C9orf72 perturbs the Ran-GTPase gradient and generates compositionally diverse cytoplasmic Importin β-1 granules in motor and cortical neurons in vivo

  2021cites this paper
• Proteostasis deregulation as a driver of C9ORF72 pathogenesis

  2021cites this paper
• Loss of nucleoporin Nup50 is a risk factor for amyotrophic lateral sclerosis

  2021cites this paper
• Mutation spectrum of amyotrophic lateral sclerosis in Central South China.

  2021cites this paper
• Mutation Screening of the GLE1 Gene in a Large Chinese Cohort of Amyotrophic Lateral Sclerosis Patients

  2021cites this paper
• Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death

  2021cites this paper
• Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation

  2021cites this paper
• The role of sex and sex Hormones in Neurodegenerative Diseases.

  2020cites this paper
• Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis

  2020cites this paper
• The role of DNA damage response in amyotrophic lateral sclerosis

  2020cites this paper
• High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines

  2020cites this paper
• Functions of Gle1 are governed by two distinct modes of self-association

  2020cites this paper
• Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases

  2020cites this paper
• Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.

  2020cites this paper
• Out or decay: fate determination of nuclear RNAs.

  2020cites this paper
• Functions of Gle1 are governed by two distinct modes of self-association

  2020cites this paper
• Nucleo–cytoplasmic transport defects and protein aggregates in neurodegeneration

  2020cites this paper
• Extension of the phenotypic spectrum of GLE1‐related disorders to a mild congenital form resembling congenital myopathy

  2020cites this paper
• Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?

  2020cites this paper
• Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.

  2020cites this paper
• Expanding Clinical Presentations Due to Variations in THOC2 mRNA Nuclear Export Factor

  2020influential citation
• Nucleocytoplasmic transport

  2019cites this paper
• Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.

  2019cites this paper
• RNA-Mediated Disease Mechanisms in Neurodegenerative Disorders.

  2019cites this paper
• New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis

  2019cites this paper
• The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration

  2019cites this paper
• The Structure of the Nuclear Pore Complex (An Update).

  2019cites this paper
• Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease

  2019cites this paper
• An ESCRT-LEM domain inner nuclear membrane protein surveillance system is poised to directly monitor the integrity of the nuclear envelope barrier and nuclear transport system

  2019cites this paper
• An ESCRT-LEM protein surveillance system is poised to directly monitor the nuclear envelope and nuclear transport system

  2019cites this paper
• Differential turnover of Nup188 controls its levels at centrosomes and role in centriole duplication

  2019cites this paper
• Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

  2019cites this paper
• Mechanisms of nuclear mRNA export: A structural perspective

  2019cites this paper
• Molecular pathomechanisms of Amyotrophic Lateral Sclerosis caused by FUS mutations

  2019cites this paper
• The Role of mRNA Transporter in Human Cancer

  2018cites this paper
• Impaired Nucleoporins Are Present in Sporadic Amyotrophic Lateral Sclerosis Motor Neurons that Exhibit Mislocalization of the 43-kDa TAR DNA-Binding Protein

  2018cites this paper
• Regulatory Potential of the RNA Processing Machinery: Implications for Human Disease.

  2018cites this paper
• Rab-dependent cellular trafficking and amyotrophic lateral sclerosis

  2018cites this paper
• Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons

  2018cites this paper
• Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.

  2018cites this paper
• Elucidating the Mechanism of mRNA Export Regulation by the Nuclear Pore Complex

  2018influential citation
• Looking for the Missing Link: Application of Copper Isotope Metallomics to Amyotrophic Lateral Sclerosis

  2018cites this paper
• Mechanisms of G4C2 derived dipeptide repeat protein toxicity in Drosophila models of C9ALS/FTD

  2018cites this paper
• ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia

  2018cites this paper
• Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.

  2018cites this paper
• Screening of GLE1 mutations in Chinese amyotrophic lateral sclerosis patients.

  2018cites this paper
• Control of CNS Functions by RNA-Binding Proteins in Neurological Diseases

  2018cites this paper
• Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect

  2018cites this paper
• Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma

  2018cites this paper
• Structural and functional analysis of mRNA export regulation by the nuclear pore complex

  2018cites this paper
• Stress Granules and ALS: A Case of Causation or Correlation?

  2018cites this paper
• RNA Degradation in Neurodegenerative Disease.

  2018cites this paper
• RNA Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases.

  2018cites this paper
• ALS Genes in the Genomic Era and their Implications for FTD.

  2018cites this paper
• ALS-associated genes display CNS expression in the developing zebrafish.

  2018cites this paper
• Repeat-associated non-ATG (RAN) translation

  2018cites this paper
• Moonlighting nuclear pore proteins: tissue-specific nucleoporin function in health and disease

  2018cites this paper
• MAPK- and glycogen synthase kinase 3–mediated phosphorylation regulates the DEAD-box protein modulator Gle1 for control of stress granule dynamics

  2018cites this paper
• The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

  2017cites this paper
• Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation

  2017cites this paper
• ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export

  2017cites this paper
• Mutant Huntingtin Disrupts the Nuclear Pore Complex.

  2017influential citation
• Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.

  2017influential citation
• Expansion of the GLE1‐associated arthrogryposis multiplex congenita clinical spectrum

  2017influential citation
• TDP‐43 and FUS en route from the nucleus to the cytoplasm

  2017cites this paper
• Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.

  2017cites this paper
• Integration of mRNP formation and export

  2017cites this paper
• Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis

  2017cites this paper
• Artificial intelligence in neurodegenerative disease research : use of IBM Watson to identify additional RNA ‐ binding proteins

  2017cites this paper
• Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons

  2017cites this paper
• TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

  2017cites this paper
• Architecture of the nuclear pore complex symmetric core

  2017influential citation
• Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

  2017cites this paper
• Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis

  2017cites this paper
• Nup42 and IP6 coordinate Gle1 stimulation of Dbp5/DDX19B for mRNA export in yeast and human cells

  2017cites this paper
• RNA Nuclear Export: From Neurological Disorders to Cancer.

  2017influential citation
• Ageing as a risk factor for ALS/FTD

  2017cites this paper